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Abstract
There were 116 articles published in the Journal of Cardiovascular Magnetic Resonance (JCMR) in 2015, which is a
14% increase on the 102 articles published in 2014. The quality of the submissions continues to increase. The 2015
JCMR Impact Factor (which is published in June 2016) rose to 5.75 from 4.72 for 2014 (as published in June 2015),
which is the highest impact factor ever recorded for JCMR. The 2015 impact factor means that the JCMR papers
that were published in 2013 and 2014 were cited on average 5.75 times in 2015. The impact factor undergoes
natural variation according to citation rates of papers in the 2 years following publication, and is significantly
influenced by highly cited papers such as official reports. However, the progress of the journal's impact over the
last 5 years has been impressive. Our acceptance rate is <25% and has been falling because the number of articles
being submitted has been increasing. In accordance with Open-Access publishing, the JCMR articles go on-line as they
are accepted with no collating of the articles into sections or special thematic issues. For this reason, the Editors have felt
that it is useful once per calendar year to summarize the papers for the readership into broad areas of interest or theme,
so that areas of interest can be reviewed in a single article in relation to each other and other recent JCMR articles. The
papers are presented in broad themes and set in context with related literature and previously published JCMR papers
to guide continuity of thought in the journal. We hope that you find the open-access system increases wider reading
and citation of your papers, and that you will continue to send your quality papers to JCMR for publication.
Technical developments
Technological progress marches on and the cardiovascular
system inspires considerable activity, because it is challen-
ging and new applications become possible as acquisition
speed increases. Recent advances reported in the journal
have included improved flow mapping, [1–3] real-time im-
aging, [4] T1 mapping, [5–7] simulations, [8, 9] perfusion,
[10–12] coronary imaging, [13] diffusion tensor imaging,
[14–16] feature tracking, [17–20] and strain assessment.
[21, 22] The full breadth of new developments is described
in the papers in the section.
Validation of in vivo 2D displacements from spiral cine
DENSE at 3T
This manuscript describes a study to investigate the
potential improvement of spiral cine DENSE when ap-
plied at 3 Tesla [23]. The study showed that the higher
field strength and associated longer T1 resulted in
higher SNR and tag persistence which allowed scanning
at a higher resolution. The authors show increases in ra-
dial strain with this increased spatial resolution and in
keeping with comparative lower field measurements,
that reproducibility for radial strain is less than for the
other measures.
Quantitative pixel-wise measurement of myocardial blood
flow. The impact of surface coil-related field inhomogeneity
and a comparison of methods for its correction
As myocardial perfusion quantitation by CMR is being
used more frequently this work represents important
evidence that will improve the accuracy of techniques
applied [24]. The results are highly relevant to the quan-
titative analysis of myocardial perfusion CMR studies.
The authors show in volunteers that correction of perfu-
sion CMR data with surface coil intensity correction im-
proves homogeneity of myocardial blood flow estimates
across the myocardium. They then show in patients that
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uncorrected estimates can lead to misclassification of
perfusion defects. They conclude with the important mes-
sage that surface coil-related field inhomogeneity can con-
found pixel-wise myocardial perfusion quantification.
FLASH proton density imaging for improved surface coil
intensity correction in quantitative and semi-quantitative
SSFP perfusion cardiovascular magnetic resonance
On a related theme this manuscript demonstrated an
improved approach to acquiring the coil correction data
for quantitative perfusion images acquired using the
SSFP sequence [25]. The work was based on the hypothesis
that the off resonance response of the conventionally used
low flip angle SSFP was very different to the higher flip
angle sequence used to acquire the perfusion data and that
this introduced errors. To overcome this problem the
authors implemented a FLASH proton density sequence
for the coil correction images, which was insensitive to off
resonance affects. The authors demonstrated the method
on 10 normal subjects and also in 10 patients where they
showed improved coefficients of variation over the whole
ventricle for quantitative myocardial perfusion and semi
quantitative measures of perfusion.
Age and gender-related normal left ventricular deformation
assessed by cardiovascular magnetic resonance feature
tracking
The method of Feature Tracking (FT) is becoming more
and more widely applied as an approach to measure-
ment of myocardial strain. This is in part because it can
easily be retrospectively applied to routinely acquired
cine images and in part because the other methods of
strain measurement have proved difficult to implement.
This manuscript has provided the first comprehensive
set of reference values for CMR feature tracking imaging
across a large age range [26]. It remains unclear exactly
how FT measures relate to true myocardial strain.
Comparison of diffusion tensor imaging by cardiovascular
magnetic resonance and gadolinium enhanced 3D image
intensity approaches to investigation of structural
anisotropy in explanted rat hearts
This paper presents an interesting large piece of work
comparing two methods of obtaining microstructural
information from ex vivo myocardial tissue: diffusion
tensor imaging; and a novel technique which derives a
structural tensor [27]. The structural tensor is obtained
from high-resolution T1-weighted imaging of fixed tissue
perfused with gadolinium contrast agent during fixation.
The contrast agent lies within myocardial shear layers,
which are visible in the high-resolution CMR data. The
authors conclude that the structural tensor framework is
reliable, robust and the preferred option for myolaminar
measurement in fixed myocardium. The approach may
well be of use in future assessment of DTI developments.
User-initialized active contour segmentation and
golden-angle real-time cardiovascular magnetic resonance
enable accurate assessment of LV function in patients with
sinus rhythm and arrhythmias
This work combines a previously described real-time
cardiac imaging sequence with an easy-to-use analysis
tool based on user-initialized active contours for seg-
mentation of the LV endocardium to extract the LV
volume for each image frame [28]. The goal of the paper
was to provide evidence that real-time CMR can accur-
ately assess beat-to-beat variation in LV function or
during an arrhythmia. In sinus rhythm patients, con-
tinuous LV volume measurements showed no significant
difference compared to clinical standard segmentation of
retrospectively-gated cine images and in arrhythmia, the
impact of ectopic beats on hemodynamic function was
demonstrated.
Impact of motion correction on reproducibility and
spatial variability of quantitative myocardial T2 mapping
In this study, the authors evaluated the impact of their
own previously published in-plane motion correction
algorithm; adaptive registration of varying contrast-
weighted images for improved tissue characterization
(ARCTIC), in quantitative myocardial T2 mapping [29].
They tested their approach on twelve healthy adult sub-
jects imaged using breath-hold, free breathing, and free
breathing with respiratory navigator gating for myocar-
dial T2 mapping sequences. Additionally fifty patients
referred for clinical CMR were imaged using the free
breathing with respiratory navigator sequence. Their
approach led to increased DICE scores, improved repro-
ducibility and improved subjective score of T2 map
quality. The authors conclude by saying their technique
“substantially reduces spatial mis-alignment among T2-
weighted images and improves the reproducibility and
spatial variability of in-vivo T2 mapping”.
Clinical experience of strain imaging using DENSE for
detecting infarcted cardiac segments
In this study into the potential clinical application of
DENSE, the authors tested its potential to uncover early
systolic changes not picked up by ejection fraction [30].
They aimed to assess whether strain obtained by strain-
encoded CMR with DENSE, could discriminate patients
with myocardial scar. The main result were that circum-
ferential strain allows the detection of segments with
more than 50% of myocardial scar and that interob-
server and scan-rescan reproducibility was high. The
conclusions were that DENSE-derived circumferential
strain may be used for the detection of myocardial
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segments with >50% scar area, the repeatability of strain
is satisfactory and that DENSE derived global strain agrees
with other global measures of left ventricular ejection
fraction.
Cardiovascular magnetic resonance compatible physical
model of the left ventricle for multi-modality
characterization of wall motion and hemodynamics
Dynamic wall motion as well as the hemodynamics of
mitral inflow and aortic outflow are all simulated [31].
Chamber morphology is studied using stereo-photography
and CMR and intra-chamber flow is evaluated using par-
ticle image velocimetry flow probes and phase contrast
CMR. CMR and stereo-photography closely agree for
volume assessment and centre plane flows from the two
measures matched. The authors claim that the model can
be used for the purposes of acquiring CMR data for valid-
ation of fluid-structure interaction simulations, determin-
ing the accuracy of cine-CMR reconstruction methods,
and conducting investigations of the effects of altering
anatomical variables on LV function under normal and
disease conditions.
Magnetic susceptibility anisotropy of myocardium
imaged by cardiovascular magnetic resonance reflects
the anisotropy of myocardial filament alpha-helix
polypeptide bonds
This paper lies at the intersection of biophysics and
magnetic resonance imaging [32]. The authors describe
an interesting investigation of the anisotropic suscepti-
bility of the tissue of the ex vivo murine heart. This
yields the important finding that the magnetic suscepti-
bility of heart muscle is anisotropic, such that the orien-
tation of the principal axis of the susceptibility tensor is
linked to the muscle fiber orientation. The measured
values of susceptibility can be reasonably explained by
using a simple compartmental model in which the an-
isotropy arises from the oriented peptide bonds in the
myofibrils. The results are interesting from a basic sci-
ence point of view and despite the many challenges also
potentially point to diagnostic utility of cardiac suscepti-
bility measurements.
Influence of phase correction of late gadolinium
enhancement images on scar signal quantification in
patients with ischemic and non-ischemic cardiomyopathy
In this study the authors sought to investigate the existence
of a systematic bias between threshold-based scar quantifi-
cation performed on conventional magnitude inversion re-
covery (MIR) and matched phase sensitive inversion
recovery (PSIR) images [33]. They carried out their study
on 80 consecutive patients, 40 with ischemic and 40
with non-ischemic myocardial fibrosis and also 40 nor-
mal volunteers. They found that MIR images, compared
with identical analysis of matched PSIR images, have
relatively higher quantified scar signal using SD from
the mean of normal, reference myocardium for Signal
Threshold Versus Reference Myocardium techniques,
and relatively lower quantified scar signal using full
width half maximum analysis. The authors conclude
that the systematic bias between MIR and PSIR based
scar quantification suggests these two techniques should
not be considered equivalent for the purposes of quantita-
tive evaluation.
Fast assessment of long axis strain with standard
cardiovascular magnetic resonance: a validation study
of a novel parameter with reference values
In this manuscript, the authors present a fast technique
for the quantification of global LV longitudinal strain
from standard CMR cine images [34]. Different approaches
for the measurement of LV longitudinal strain were tested
retrospectively in 125 patients with various forms of car-
diomyopathy as well as in 40 controls. Strain derived from
the distance of the epicardial apical border to the midpoint
of the line connecting the mitral valve insertion points
proved to be the most reliable approach. The method per-
formed similarly to Feature Tracking for discriminating
controls from patients and was considerably quicker. Addi-
tionally, the approach performed significantly better than
MAPSE and the measurement of ejection fraction.
Cardiovascular magnetic resonance phase contrast
imaging
With the recent increased interest in CMR 4D Flow de-
velopments there has been relatively little attention more
general 2D and developments for more routine clinical
flow measurement applications. This review of phase-
contrast CMR nicely addresses this limitation [35]. The
manuscript includes an educational technical description
of the technique mainly aimed at the more technically
minded with a background in other CMR techniques
and also includes a review of clinical applications and
emerging research.
Systolic ShMOLLI myocardial T1-mapping for improved
robustness to partial-volume effects and applications in
tachyarrhythmias
A real problem for the measurement of T1 by CMR is
encountered when patients or subjects have arrhythmia.
This paper looks to address the issue of assessment of
T1 mapping in tachyarrhythmia by investigating whether
images can be acquired in systole for this [36]. T1 maps
were acquired using ShMOLLI at 1.5T in 10 healthy
volunteers with various systolic trigger delays and also a
conventional diastolic delay. A shorter readout was also
implemented, to explore the effect of reducing image read-
out time and sensitivity to systolic motion. The feasibility
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and image quality of systolic T1 mapping was tested in 15
patients with tachyarrhythmia. The results showed reduced
T1 variability in normals and in patients with tachyarrhyth-
mia, systolic ShMOLLI T1-mapping was shown to over-
come mis-triggering problems. For quantification there
was a small overall effect on T1 values, with slightly shorter
T1 values in systole compared to diastole.
The effect of high-permittivity pads on specific absorption
rate in radiofrequency-shimmed dual-transmit cardiovascular
magnetic resonance at 3T
A particular problem that can affect CMR at 3T is the
issue of B1 field inhomogeneity. This work analyses the
effects on B1 homogeneity and SAR when a pair of high
permittivity (HP) pads are used in combination with a
commercial dual-cannel TX setup [37]. In a previous work
the same group presented the design and optimization of
the HP pads. The current work extends the concept
through a further evaluation of B1 homogeneity and
SAR for different B1 shim settings (amplitude and
phase differences between channels) without and with
the HP pads. They show that the combination of active
(dual transmit) and passive (HP pads) RF shimming
generally increases image quality for cardiac imaging at
3 T. In most practical cases optimized RF shim settings
result in increased B1 and homogeneity and reduced
SAR with the HP pads. However, there are cases in
which SAR might be underestimated which is concerning
for safety and indicates the need further investigation.
Saturation pulse design for quantitative myocardial
T1 mapping
This excellent paper highlights the importance of asses-
sing, controlling and improving underlying basic elements
of CMR acquisition sequence parameters that have a sig-
nificant impact on the validity of findings in clinical stud-
ies [38]. The authors present a thorough analysis of
improved saturation pulse designs for SASHA T1 map-
ping. They include 1.5T and 3T field strengths, and in-
clude the two important classes of pulses. They also
characterize the connection between saturation imperfec-
tions and T1 errors. The authors conclude that Adiabatic
and Pulse Train Saturation pulses optimized for different
constraints found at 1.5T and 3T achieved <1% residual
|MZ/M0| in phantom experiments, enabling greater ac-
curacy in quantitative saturation recovery T1 imaging.
Validation of high temporal resolution spiral phase
velocity mapping of temporal patterns of left and right
coronary artery blood flow against Doppler guidewire
In this manuscript, the authors describe a prospective
study comparing velocities measured using a novel spiral
phase contrast velocity CMR sequence to those measured
by Doppler guidewire, in 8 right and 15 left coronary
arteries [39]. The paper describes the validation of a novel
spiral PCMR sequence for use in coronary arteries and
proposes the technique as a non-invasive alternative to
Doppler. The results show that when corrected for dif-
ferences in heart rate between the two studies, MR
mean velocity through the cardiac cycle, peak systolic vel-
ocity (PSV) and peak diastolic velocity (PDV) showed a
moderate to good linear relationship between the two
techniques. MR values of PDV/PSV showed a strong
linear relationship with Doppler values with a slope close
to unity. The authors conclude that high temporal reso-
lution breath-hold spiral phase velocity mapping under-
estimates absolute values of coronary flow velocity but
allows accurate assessment of the temporal patterns of
blood flow.
Gadolinium free cardiovascular magnetic resonance with
2-point Cine balanced steady state free precession
Recently, there has been particular interest in the de-
velopment of non-contrast alternatives to the routinely
applied contrast enhanced CMR sequences [40]. In this
work, the idea that Magnetization Transfer (MT) sen-
sitivity of the balanced SSFP signal can be used to
characterize the myocardium is revisited in a refined
form. The authors present their technique based on re-
peating the sequence with different flip angles for im-
aging of scar and edema. The technique was evaluated
in patients and showed good correlation with LGE. In
the 23 who demonstrated areas of myocardial enhance-
ment with LGE the association between LGE and their
measure ΔS/So was strong. Bland-Altman analysis re-
vealed a slight bias towards larger volume of enhancement
with ΔS/So compared to LGE, and similar transmurality.
The authors concluded that the method identified tissue
that enhances at LGE with strong association to GPC and
their results suggest that with further development, MT-
weighted CMR could be used similarly to LGE for diag-
nostic imaging.
2D cine DENSE with low encoding frequencies accurately
quantifies cardiac mechanics with improved image
characteristics
This note reports the effect of the displacement encoding
strength on the measurement of displacement and strain
using DENSE phase encoded myocardial function evalu-
ation [41]. Spiral DENSE is becoming established as a
good method of characterizing regional myocardial strain.
In this work acquisitions at 3T in healthy volunteers and
patients, at various encoding strengths were performed
and compared. Circumferential and radial strain and
ventricular twist were evaluated. The conventionally used
encoding strength of 0.1 cycles/mm has been shown result
in significant phase wrapping that significantly compli-
cates the processing. This study showed that for 2D cine
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DENSE with through-plane dephasing, the encoding fre-
quency can be lowered to 0.04 cycles/mm without com-
promising the quantification of twist or strain.
Breath-hold imaging of the coronary arteries using
quiescent-interval slice-selective (QISS) magnetic resonance
angiography: pilot study at 1.5 Tesla and 3 Tesla
In this study, the authors describe the adaption of the
Quiescent-Interval Slice-Selective (QISS) noncontrast MRA
method from peripheral MRA to breath-held coronary
MRA [42]. The technique was tested at 1.5T and 3T and
with both radial and Cartesian k-space trajectories. The left
coronary system was imaged in 6 normal volunteers and 1
patient with mild coronary artery disease, and compared to
a breath-held T2-prep 2D sequence and a standard 3D
free-breathing bSSFP sequence. The QISS sequence is a
single-shot or two-shot 2D sequence with a slice-selective
inversion recovery preparation that suppresses background
tissue. This method can be used to collect 10-20 slices in a
long breath-hold, although less slices with a shorter breath-
hold may be more suitable for patients. Results showed that
overall, the image quality with the breath-hold multislice
2D QISS technique is very impressive and compares visu-
ally favorably with the free-breathing 3D coronary bSSFP
scan. Cartesian QISS provided the best coronary-to myo-
cardium CNR, whereas radial QISS provided the sharpest
coronary images. QISS image quality exceeded that of free-
breathing 3D coronary MRA with few artifacts at either
field strength. The authors conclude that, with further
clinical validation, QISS might provide an efficient al-
ternative to commonly used free-breathing coronary
MRA techniques.
Parallel simulations for QUAntifying RElaxation magnetic
resonance constants (SQUAREMR): an example towards
accurate MOLLI T1 measurements
In another study towards improving the accuracy of T1
mapping, the authors have incorporated a relaxation
time sequence simulator based on a general sequence
simulator that had been described previously [43]. Using
this the authors studied the improvement in accuracy
for T1 mapping when using a strategy for determining
T1 based on imaging signal intensities and simulations
of the relationships between signals and sequence acqui-
sition parameters. The proposed strategy was evaluated
in phantoms compared to reference techniques and also
in four healthy volunteers. T1 mapping schemes were per-
formed where for every experiment, the identical pulse se-
quence was simulated for a large range of physiological
combinations of relaxation constants, resulting in a data-
base of all possible outcomes. The unknown relaxation
constants were then determined by finding the simulated
signals in the database that produced the closest fit to the
measured signal intensities. The authors believe the
method will allows for correction of quantitative CMR
data that have already been acquired as well as improving
data consistency and advancing quantitative CMR across
imaging centers.
Segmented nitinol guidewires with stiffness-matched
connectors for cardiovascular magnetic resonance
catheterization: preserved mechanical performance and
freedom from heating
In the field of Interventional CMR there has been a real
need for a guidewire that is mechanically strong, is
trackable, and has the required bend along its length.
It also needs to be safe in terms of potential for RF
heating. The passive guidewire described in this study
is a segmented-core nitinol device constructed using
short nitinol rod segments [44]. Mechanical integrity
was tested according to International Organization for
Standardization (ISO) standards. CMR RF heating
safety was tested in vitro in a phantom according to
American Society for Testing and Materials (ASTM)
F-2182 standard, and in vivo in seven swine. Results
were compared with a high-performance commercial
nitinol guidewire. The guidewire exhibited similar
mechanical behavior to the commercial comparator.
RF heating was reduced from 13 °C in the commercial
guidewire to 1.2 °C in the described wire, using a flip
angle of 75°. The guidewire was conspicuous during
left heart catheterization in swine. The authors finally
conclude that clinical translation is imminent.
Positive contrast spiral imaging for visualization of
commercial nitinol guidewires with reduced heating
Based on the lack of novel MR compatible guidewires,
in this work the same group have also studied the de-
velopment of sequences for safe use with conventional
commercial guidewires [45]. For improved catheter
visualization positive contrast was achieved using
through-slice dephasing such that the guidewire ap-
peared bright and the background signal suppressed.
Positive contrast images were interleaved with ana-
tomical images, and real-time image processing was
used to produce a color overlay of the guidewire on the
anatomy. Left heart catheterization was performed in a
porcine model with a frame rate of over 6 frames per
second. In comparison to the conventional Cartesian real-
time imaging sequence, temperature increases reduced
from 50 °C (phantom) and 4 °C (in vivo) to 0.37 °C
(phantom) and 0.06 °C (in vivo). Visualization and
localization of interventional devices (especially guide-
wires) using CMR is one of the challenging issues that
are currently holding interventional CMR from becoming
a clinical reality.
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T1 Mapping and ECV
There has been significant progress in developing stan-
dardised protocols of acquisition and analysis for T1
mapping. Its research use is still growing [46]. Much re-
mains to be achieved in converting these efforts into
substantive clinical applications, although the first of these
looks to be in the assessment of cardiac amyloidosis.
Single bolus versus split dose gadolinium administration
in extra-cellular volume calculation at 3 Tesla
There is established evidence that ECV calculated using
either an infusion or bolus of contrast agent is reprodu-
cible, and correlates well with fibrosis measured on myo-
cardial biopsy specimens. However an area of contention
is whether a split dose of contrast as is commonly used
in adenosine stress perfusion protocols affects ECV and
how this correlates with previously validated methods.
In this study of 5 patients and 10 healthy volunteers,
split dose contrast T1 mapping, in keeping with a stress
perfusion protocol, was reproducible and correlated well
with bolus contrast administration [47]. These findings
support that ECV measurement maybe incorporated
into stress perfusion protocols in both clinical and re-
search CMR.
The association between cardiovascular risk and
cardiovascular magnetic resonance measures of fibrosis:
the Multi-Ethnic Study of Atherosclerosis (MESA)
Risk scores to predict endpoints in patients without
symptomatic CVD are an increasingly important tool to
help identify individuals who may benefit from more in-
tensive or earlier medical intervention. Most risk models
use similar risk factors to predict cardiovascular events.
These models accordingly may also be expected to show
similar trends in relationship to CMR fibrosis. In this
study, greater CVD risk by most risk scores was associ-
ated with greater myocardial fibrosis as identified by
CMR in men [48]. T1 times showed improved relation-
ship to CVD risk scores, compared to other CMR mea-
sures such as ECV, native and 12 min T1 time. For
women, who are generally categorized as lower risk than
men in CVD models, there was generally little or no re-
lationship between CVD risk score and T1 time or ECV.
Characterization of myocardial T1-mapping bias caused
by intramyocardial fat in inversion recovery and saturation
recovery techniques
Measurement of the myocardial T1 by current T1-
mapping methods that use b-SSFP protocols is subject
to bias when there is a mixture of myocardium and fat.
The presence of fat leads to a bias in T1 measurement.
Partial volume of myocardium and fat occurs at tissue
boundaries and in cases of intramyocardial fat. Intra-
myocardial fat is frequently present in scar tissue such as
chronic MI due to the process of lipomatous metaplasia,
and is also present in non-ischemic cardiomyopathies. In
this study, simulations were performed to illustrate the be-
havior of mono-exponential fitting to bi-exponential mix-
tures of myocardium and fat with varying fat fractions
[49]. Both inversion recovery and saturation recovery im-
aging protocols using balanced steady state free precession
were considered. In-vivo imaging with T1-mapping,
water/fat separated imaging, and late enhancement im-
aging was performed on subjects with chronic myocardial
infarction. In cases of lipomatous metaplasia, the T1 biases
in b-SSFP imaging protocols were found to be additive or
subtractive depending on whether the center frequency
corresponds to the myocardium and fat being in-phase or
out-of-phase, respectively. It is important to understand
this mechanism which may otherwise lead to erroneous
interpretation.
Extracellular volume quantification in isolated
hypertension - changes at the detectable limits?
Arterial hypertension results in increasing arterial stiffness
and afterload, leading to remodelling of the myocardium
due to cardiomyocyte hypertrophy, fibroblast stimulation
and then increased collagen formation. Progressive diffuse
myocardial fibrosis and left ventricular hypertrophy are
recognised. In this study of well-controlled hypertensive
patients from a specialist tertiary centre, of 46 hyperten-
sive patients and 50 healthy volunteers, native myocardial
T1 was similar in hypertensives and controls (955 ± 30 ms
versus 965 ± 38 ms, p = 0.16) [50]. The difference in ECV
did not reach significance (0.26 ± 0.02 versus 0.27 ± 0.03,
p = 0.06). In the subset with LVH, the ECV was signifi-
cantly higher (0.28 ± 0.03 versus 0.26 ± 0.02, p < 0.001).
Overall, T1 mapping revealed increased diffuse myocardial
fibrosis, but the increases were small and only occurred
with LVH.
Increased myocardial extracellular volume in active
idiopathic systemic capillary leak syndrome
Systemic Capillary Leak Syndrome (SCLS) is a rare
understudied disorder of unknown etiology, with few ef-
fective therapies, and without specific biomarkers or
diagnostic tests. Using T1 mapping, it was noted in 26
patients that patients with SCLS have a significantly
higher myocardial ECV than age-matched controls [51].
Elevations in ECV are most pronounced in patients with
a recent SCLS flare or patients with a chronic form of
SCLS. Myocardial ECV may serve as a diagnostic marker
of SCLS and may aid in the evaluation of future treat-
ments and prognosis in this rare disorder.
T2 Mapping
Over recent years, the CMR literature has been largely
dominated by work on the development and application
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of T1 mapping techniques. There is now renewed inter-
est in parametric T2 based techniques that will facilitate
more quantitative and sensitive assessment for myocar-
dial oedema and inflammation than is generally achieved
with conventional T2-weighted sequences. The following
manuscripts suggest a number of newer techniques have
the potential to provide superior quantitative T2 assess-
ment rapidly and with high reproducibility. As with T1
mapping techniques, defining the optimal sequence pa-
rameters is paramount and reference ranges also appear
to be sequence dependent.
Cardiac T2-mapping using a fast gradient echo spin echo
sequence - first in vitro and in vivo experience
This manuscript presents the work of one of the groups
evaluating a novel Gradient Spin Echo (GraSE) sequence
for more efficient and accurate myocardial T2 mapping
[52]. They compared the more rapid newer technique
with two previously introduced T2-mapping techniques
(a Multi Echo Spin Echo (MESE) technique and a T2-
prepared bSSFP technique) in a gel phantom and 12
healthy volunteers at 1.5 T. In the phantom study, the
T2 values derived by the GraSE sequence were closer to
the MESE reference than were those derived by the T2-
prepared sequence; both the GraSE and T2-prepared se-
quences overestimated T2 when compared to MESE.
This work revealed some of the potential promise of this
T2-mapping sequence, while highlighting the need for
systematic comparison of the different cardiac T2-mapping
sequences and the requirement for sequence specific
reference ranges.
Gradient Spin Echo (GraSE) imaging for fast myocardial
T2 mapping
In this manuscript, the authors also implemented and
tested a novel myocardial T2 mapping sequence based
on gradient-spin-echo (GraSE) to enable rapid quantita-
tive T2 assessment with a single breath sequence at 1.5T
[53]. The authors tested four sequence variants in a
phantom and in 20 healthy volunteers and apply the se-
quence with the best performance to five patients. The
authors reported impressive intra-reader and inter-reader
agreement (mean differences of -0.1 ms and 0. 1ms re-
spectively for the optimized 6-echo GraSE sequence) such
that GraSE imaging may challenge previous T2 mapping
techniques. The manuscript also highlights the import-
ance of well-defined sequence settings.
Myocardial T2 mapping reveals age- and sex-related
differences in volunteers
Having performed experiments in muscle phantoms, the
authors examine T2 values in 74 volunteers (including
subjects with hypertension and diabetes) divided into
two groups by age, using a turbo gradient spin-echo
(GraSE) sequence at 1.5T [54]. As in the previous
manuscript, the authors showed high reproducibility
(intra- and inter-observer correlations with R2 = 0.91
and R2 = 0.94 as well as a coefficients of variation of 2.4%
and 2.2%, respectively) using this technique which they
found to be 6 times faster than a standard multi-echo
spin-echo sequence. Quantified by freeze-drying of muscle
specimens, they found myocardial T2 values to correlate
with tissue water. The authors reported global T2 time
to be significantly shorter towards the base of the heart
(p < 0.01) and higher in female subjects in all short axis
slices (p < 0.01). They found no correlation of segmental
T2 values with myocardial strain, but found the older
volunteers group to have significantly increased mean T2
values compared to the younger volunteers (all p < 0.01).
This manuscript highlights age- and sex-related differ-
ences in absolute T2 values as evident in the volunteers,
acknowledging that specific reference values are highly
dependent on the method used such that specific reference
values will be required for each T2-mapping method.
Mapping tissue inhomogeneity in acute myocarditis:
a novel analytical approach to quantitative myocardial
edema imaging by T2-mapping
The authors retrospectively investigated T2-mapping
data acquired using their previously described breathold
Gradient-Spin-Echo sequence at 1.5 T in 31 patients
with acute myocarditis and compared these to a control
cohort of 30 healthy volunteers [55]. Although the
authors found higher T2 values in patients than in
volunteers, there was considerable overlap with mean
patient values still lying within the normal range of
volunteers. The authors undertook extensive statistical
analysis to propose the combination of highest segmen-
tal T2 value within each patient and the mean absolute
deviation of logarithm transformed pixel-standard devi-
ation of T2 as a potential novel discriminator of patients
from controls. They report that combining these enabled
83% specificity and 81 sensitivity for detection of acute
myocarditis and that this could overcome the limitation
imposed by overlapping T2 values on the clinical adoption
of T2-mapping, but this requires more extensive evalu-
ation. These data further highlight the overlap between
myocardial T2 values in supposedly diseased and normal
myocardium, as often observed with T1-mapping.
T2 mapping of the heart with a double-inversion radial
fast spin-echo method with indirect echo compensation
The authors present a technical development in cardiac
T2 mapping, detailing a black blood double-inversion re-
covery radial fast spin-echo (DIR-RADFSE) technique
which offers superior spatial and temporal resolution to
T2-SSFP methods [56]. They evaluated this sequence in
phantoms, 7 healthy volunteers and two subjects with
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heart disease, assessing data quality and reproducibility
at 1.5 T. Two different computed methods (an echo
sharing (ES) algorithm and a model-based CURLIE-
SEPG algorithm) for addressing the highly undersampled
k-space filling approach used to limit breathhold time
were compared. Both reconstruction algorithms yielded
echo time images with high spatiotemporal resolution,
but the accuracy and reproducibility of the CURLIE-
SEPG T2 estimates were superior to those of the ES
algorithm, although ES reconstruction was faster than
the model-based approach. The authors suggest en-
hanced image quality to relate to reduced misregistration
between data sets with image registration being un-
necessary given that T2 mapping can be performed in a
voxel-wise manner.
Cardiomyopathy
The phenotyping of cardiomyopathy is a primary clinical
indication for CMR, and has become mainstream in
hypertrophic cardiomyopathy, [57–59] including the de-
velopment of hypertrophy atlases [60]. Recent attention
has been focussed on T1 imaging for the assessment of
diffuse fibrosis in cardiomyopathy, [61, 62] with T1
standardisation, [63] technical developments, and the as-
sessment of diffuse fibrosis in cardiomyopathy. Progress
has been prominent in a wide range of unusual condi-
tions including myocarditis, [64, 65] muscular dystrophy,
[66, 67] myotonic dystrophy, [68] ARVC, [69, 70] sys-
temic sclerosis, [71] non-compaction, [72, 73] radiation,
[74] cocaine toxicity, [75] and iron loading. [76–78] This
section describes further advances in this field.
A disproportionate contribution of papillary muscles and
trabeculations to total left ventricular mass makes choice
of cardiovascular magnetic resonance analysis technique
critical in Fabry disease
In the era of enzyme replacement therapy and the tar-
geting of this therapy to those with identified end-organ
involvement, the volumetric contribution of papillary
muscles and trabeculations in Fabry disease is signifi-
cantly increased relative to healthy controls in males. It
is important to account for this to avert significant
underestimation of LV Mass and misclassification of a
proportion of subjects. While Fabry patients represent a
small percentage of patients with hypertrophy, they
underline the importance of accurately contouring the
endocardial border for quantification of left ventricular
assessment [79].
Focal myocardial fibrosis assessed by late gadolinium
enhancement cardiovascular magnetic resonance in
children and adolescents with dilated cardiomyopathy
Mid-wall fibrosis using CMR is seen in adult patients
presenting with non-ischemic dilated cardiomyopathy
(DCM). In these studies, LGE is associated with pro-
nounced LV remodelling and predicts adverse cardiac
outcomes. The significance of these findings in a paedi-
atric population is less clear. The purpose of this study
was to determine the presence and patterns of LGE in
children and adolescents with DCM [80]. The authors
report that focal histologically proven myocardial fibrosis
was rarely detected by LGE CMR despite marked LV
dilatation and severely depressed LV function. LGE oc-
curred in various patterns and mostly in patients with in-
flammatory cardiomyopathy. It remains unclear whether
myocardial fibrosis in childhood DCM reflects different
endogenous repair mechanisms that enable favourable re-
verse remodelling. Further work is required to assess the
prognostic significance of LGE in children with DCM.
Histological Validation of measurement of diffuse
interstitial myocardial fibrosis by myocardial
extravascular volume fraction from Modified Look-Locker
imaging (MOLLI) T1 mapping at 3T
Extracellular volume fraction (ECV) measured by CMR
has been proposed as a non-invasive method for assess-
ment of diffuse myocardial fibrosis, but few studies have
used 3T CMR to measure ECV. Therefore the authors
aimed to validate measurement of ECV by MOLLI T1
mapping by 3T CMR against fibrosis measured by histo-
pathology [81] The average amount of interstitial fibrosis
by picrosirius red staining in biopsy samples was 6.1 ±
4.3%. ECV computed from pre-post contrast MOLLI T1
time changes was 28.9 ± 5.5%, and correlated (r = 0.78,
p < 0.001) strongly with the magnitude of histological
fibrosis. Neither the amount of LGE (r = 0.17, p = 0.36)
nor native pre-contrast myocardial T1 time (r = −0.18,
p = 0.32) correlated with fibrosis by histopathology. The
authors concluded that ECV determined by 3T CMR
T1 MOLLI images closely correlated with histologically
determined diffuse interstitial fibrosis, providing a non-
invasive estimation for quantification of interstitial fi-
brosis in patients with valve diseases.
Characteristic cardiac phenotypes are detected by
cardiovascular magnetic resonance in patients with
different clinical phenotypes and genotypes of
mitochondrial myopathy
Mitochondrial myopathies (MM) are a heterogeneous
group of inherited conditions resulting from a primary
defect in the mitochondrial respiratory chain with con-
secutively impaired cellular energy metabolism. This
study aimed to characterize the prevalence and pattern
of cardiac abnormalities and to test the additional diag-
nostic value of CMR in this patient population [82]. Based
on assessment of 64 MM patients, cardiac involvement
was a frequent finding in MM patients. Despite a high
variability in clinical presentation, in patients with chronic
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progressive external ophthalmoplegia (CPEO)/Kearns-
Sayre syndrome (KSS) patients typically showed an
intramural pattern of LGE. MELAS patients were char-
acterized by overt concentric hypertrophy and a rather
unique, focally accentuated and diffusely distributed
LGE.
Comparison of cardiovascular magnetic resonance
characteristics and clinical consequences in children and
adolescents with isolated left ventricular non-compaction
with and without late gadolinium enhancement
Left ventricular non-compaction (LVNC) is a genetically
and clinically heterogeneous cardiomyopathy character-
ized by numerous prominent trabeculations, progressive
myocardial dysfunction, malignant ventricular arrhyth-
mias, and early mortality It accounts for about 9% of
cardiomyopathy in childhood. In this study, the authors
assembled a large cohort of children with LVNC, defined
by eligibility for CMR, to characterize and compare
CMR features and clinical outcomes in children with
LVNC with and without LGE [83]. LGE was present in
up to one-fourth of children with LVNC. LGE+ children
exhibited a more maladaptive LV remodeling and a
higher incidence of cardiovascular death and heart
transplantation.
Abnormal septal convexity into the left ventricle occurs in
subclinical hypertrophic cardiomyopathy
Approximately 60% of cases are caused by inherited
sarcomeric protein mutations. However these mutations
may have incomplete expression with a variable pheno-
type and age-related expression. Genotyping may help
identify this but is sometimes inconclusive or non-
contributory. There is however, a subtle subclinical phase
of HCM. In this study, septal convexity was increased in
G + LVH- compared to controls with longer anterior mi-
tral valve leaflet, higher relative wall, higher LV ejection
fraction and smaller LV end-systolic volume index [84].
Other morphologic measurements (LV angles, sphericity
index, and eccentricity index) were not different between
G + LVH- and controls. Septal convexity is an additional
previously undescribed feature of subclinical HCM.
Cardiovascular magnetic resonance predictors of clinical
outcome in patients with suspected acute myocarditis
The natural history of acute myocarditis (AM) remains
highly variable and prognostic stratification is of critical
importance. In a single-centre longitudinal prospective
study, 203 routine consecutive patients with an initial
CMR-based diagnosis of AM were followed over a mean
period of 18.9 ± 8.2 months. In routine consecutive pa-
tients without severe hemodynamic compromise a num-
ber of CMR parameters including the presence and
extent of myocardial edema and the extent of late
gadolinium-enhanced LV myocardial lesions were not
predictive of outcome [85]. The only independent CMR
predictor of adverse clinical outcome was an initial alter-
ation of LVEF.
Cardiovascular magnetic resonance techniques and
findings in children with myocarditis: a multicenter
retrospective study
Viral myocarditis is an important cause of morbidity and
mortality in both children and adults. This study aimed
to describe the clinical presentation, CMR protocols and
findings, and outcomes in a large, multicenter cohort of
children with myocarditis. Despite significant practice
variation in imaging protocol among centers, CMR had
a high sensitivity for the diagnosis of myocarditis in
pediatric patients [86]. Abnormalities were most often
seen with LGE followed by T2W, EGE, and first-pass
contrast perfusion. The authors note that these findings
should be useful in designing future prospective studies.
Patients with exercise-associated ventricular ectopy
present evidence of myocarditis
The origin and clinical relevance of exercise-induced
premature ventricular beats (PVBs) in patients without
structural heart disease such as myocardial infarction,
coronary artery disease, left ventricular hypertrophy, car-
diomyopathies or significant valvular disease is unknown.
In this study, the authors examined 162 consecutive pa-
tients presenting with palpitations and documented
exercise-induced premature ventricular beats (PVBs)
but no history or evidence of structural heart disease
[87]. Results were compared with 70 controls matched
for gender and age. ECG-triggered, T2-weighted, fast
spin echo triple inversion recovery sequences and late
gadolinium enhancement were obtained as well as LV
function and dimensions. The majority of patients with
exercise-associated premature ventricular beats present
evidence of myocardial disease consistent with acute or
previous myocarditis or myopericarditis.
Cardiovascular magnetic resonance findings in patients
with PRKAG2 gene mutations
PRKAG2 cardiac syndrome is an autosomal dominantly
inherited metabolic heart muscle disease characterized
by left ventricular hypertrophy (LVH), progressive con-
ducting abnormalities and ventricular pre-excitation.
The prevalence is approximately 0.23–1% in patients
with hypertrophic cardiomyopathy; it does however ac-
count for a greater proportion of HCM in children and
adolescents. Patients may benefit from early identifica-
tion due to high risk of complete atrioventricular block
and sudden cardiac death caused by atrial fibrillation
and rapid antegrade conduction through an accessory
pathway. In this study, CMR and genetic testing were
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performed in two families harboring PRKAG2 mutations
[88]. PRKAG2 cardiac syndrome may present with eccen-
tric distribution of LVH, involving focal mid-infero-lateral
pattern in the early disease stage, and more diffuse pattern
but focusing on interventricular septum in advanced
cases. In patients at earlier stages of disease, without LGE,
T1 values may be reduced, while in the advanced disease
stage T1 mapping may result in higher values caused by
fibrosis.
Myocardial tissue characterization in Chagas' heart
disease by cardiovascular magnetic resonance
Trypanosoma cruzi infection is responsible for the Chagas’
disease (CD), a major public health issue in South America
with an estimated of 13% of Latin American population
at risk of contracting this disease. With an annual inci-
dence of 29,925 cases in 21 Latin American countries, this
disease still affects approximately 5.7 million people with
an average of 12,500 deaths per year. Chagas’ heart disease
is the most serious complication The asymptomatic phase
can last for decades, corresponding to the clinical indeter-
minate phase (IND), until unknown triggers initiate the
progression to arrhythmias and heart failure in a subset,
which represents approximately one third of the patients.
Fifty-four patients were analyzed. Increase in T2-weighted
(T2W) myocardial signal intensity and T1-weighted myo-
cardial early gadolinium enhancement (MEGE) could be
detected by CMR in patients throughout all phases of
Chagas’ heart disease, including its subclinical presenta-
tion (IND) [89]. Moreover, findings were parallel to myo-
cardial fibrosis (LGE) in extent and location and also
correlated with the degree of Chagas’ heart disease clinical
severity. These findings contribute to further the know-
ledge on pathophysiology of Chagas’ heart disease, and
may have therapeutic and prognostic utility in the future.
Contrast-free detection of myocardial fibrosis in
hypertrophic cardiomyopathy patients with
diffusion-weighted cardiovascular magnetic resonance
Previous studies have shown that diffusion-weighted
cardiovascular magnetic resonance (DW-CMR) is highly
sensitive to replacement fibrosis of chronic myocardial
infarction. The authors evaluated this technique to de-
tect diffuse myocardial fibrosis in hypertrophic cardio-
myopathy (HCM) patients and compare its performance
with established CMR techniques [90]. DW-CMR is a
contrast-free non-invasive quantitative technique that
was found to be sensitive to diffuse presentations of
myocardial fibrosis. When compared to the established
contrast-enhanced ECV-CMR, DW-CMR was able to
yield comparable detection and characterization of myo-
cardial fibrosis. DW-CMR is a promising tool but re-
quires more robustness and shorter scan times in order
for it to feasibly be an effective LGE or ECV contrast-
free alternative used in a clinical setting.
T1 at 1.5T and 3T compared with conventional T2* at
1.5T for cardiac siderosis
Myocardial black blood T2* relaxometry at 1.5T pro-
vides robust, reproducible and calibrated non-invasive
assessment of cardiac iron burden. In vitro data has
shown that like T2*, novel native T1 shortens with in-
creasing tissue iron. The relative merits of T1 and T2*
are largely unexplored. In this study, the authors com-
pared the established 1.5T black blood T2* technique
against native T1 values at 1.5T and 3T in iron overload
patients and in normal volunteers [91]. T1 mapping at
1.5T and at 3T identified individuals with significant iron
loading but there was significant scatter between results
which may reflect measurement error, a T1 interaction
with T2*, or a differential sensitivity to aspects of iron
chemistry or other biology. Hurdles to clinical imple-
mentation of T1 include the lack of calibration against
human myocardial iron concentration, no demonstrated
relation to cardiac outcomes, and variation in absolute
T1 values between scanners, which makes inter-centre
comparisons difficult. The relative merits of T1 at 3T
versus T2* at 3T require further consideration.
Free-breathing T2* mapping using respiratory motion
corrected averaging
Pixel-wise T2* maps based on breath-held segmented
image acquisition are prone to ghost artefacts in in-
stances of poor breath-holding or cardiac arrhythmia.
Single shot imaging is inherently immune to ghost type
artefacts. The authors proposes a free-breathing method
based on respiratory motion corrected single shot im-
aging with averaging to improve the signal to noise ratio
[92]. This demonstrated consistently good quality maps
in the presence of respiratory motion and arrhythmias.
Free-breathing myocardial T2* mapping using GRE-EPI
and automatic Non-rigid motion correction
Measurement of myocardial T2* is widely used to assess
patients for cardiac iron overload. The conventional
breath-hold, ECG-triggered, segmented, multi-echo gra-
dient echo (MGRE) sequence used for myocardial T2*
quantification is sensitive to respiratory motion and
yields artefacts in patients who are unable to breath-
hold. The authors proposes a free-breathing myocardial
T2* mapping approach that combines a single-shot
gradient-echo echo-planar imaging (GRE-EPI) sequence
for T2*-weighted image acquisition with automatic non-
rigid motion correction (MOCO) of respiratory motion
between single-shot images [93]. The free-breathing
approach enabled accurate myocardial and liver T2*
measurements and was insensitive to respiratory motion.
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Myocardial T2* mapping: influence of noise on accuracy
and precision
Pixel-wise, parametric T2* mapping is emerging as a
means of automatic measurement of iron content in tis-
sues. It enables quick, intuitive interpretation and pro-
vides the potential benefit of spatial context between
tissues. However, pixel-wise mapping uses much lower
SNR data to estimate T2* when compared to region-
based mapping thereby decreasing both its accuracy and
precision. In this study, the effects that noise has on the
precision and accuracy of pixel-wise T2* mapping were
investigated [94]. Non-linear regression with automatic
truncation was shown to be the best mapping technique
for improving accuracy and precision in low T2* and
low SNR measurements. A formulation for estimating
pixel-wise standard deviation (SD) maps for T2* that
can serve as a quality map for interpreting images and
for comparison of imaging protocols was also proposed
and validated.
Perfusion
The use of CMR to assess myocardial perfusion has
grown substantially, including assessment of global per-
fusion reserve, [95] perfusion quantification, [96] and
comparison with fractional flow reserve [97]. Ongoing
development continues as described in this section.
Feasibility of high-resolution quantitative perfusion
analysis in patients with heart failure
Assessment of myocardial perfusion in heart failure (HF)
can be challenging due to left ventricular remodelling
and wall thinning, coexistent scar and respiratory arte-
facts. This study assessed the feasibility of CMR stress
perfusion in 58 patients with HF (LVEF ≤ 50%) and sus-
pected coronary artery disease [98]. All subjects under-
went quantitative first-pass adenosine stress perfusion
imaging using a high-resolution 3T kt perfusion se-
quence and voxel-wise Fermi deconvolution. Over half
of the HF subjects had underlying ischaemic aetiology.
Perfusion abnormalities were seen amongst patients with
ischaemic HF, whilst no regional perfusion defect was
observed in the non-ischaemic HF group. Good agree-
ment was found between visual and quantitative analysis
by absolute stress perfusion rate, myocardial perfusion
reserve (MPR) and endocardial-epicardial MPR ratio.
These results demonstrate the feasibility of high-resolution
voxel-wise perfusion assessment in patients with HF.
Quantification of myocardial perfusion with self-gated
cardiovascular magnetic resonance
Current myocardial perfusion measurements are ECG-
gated, but its use can be hindered when there is poor ECG
signal. The authors tested a newly developed ungated per-
fusion sequence made from continuously acquired datasets
which were retrospectively binned ("self-gated") into the
systole and diastole using an iterative spatio-temporal re-
construction model [99]. The ungated acquisition was
compared against the same sequence with ECG-gating as a
ground truth in 7 controls. Regional myocardial blood flow
estimates (MBFs) obtained using self-gated systole, self-
gated diastole and ECG-gated scans were similar in these
normal subjects at rest. The self-gated technique for quan-
tification of regional myocardial perfusion could contribute
to making quantitative CMR more accessible.
Measurement of myocardial blood flow by cardiovascular
magnetic resonance perfusion: comparison of distributed
parameter and Fermi models with single and dual bolus
Mathematical modeling of CMR perfusion data allows
quantification of myocardial blood flow. Fermi deconvo-
lution is a popular model but overestimates myocardial
blood flow in single bolus analysis due to arterial input
function saturation. Dual bolus injection protocols have
been suggested to eliminate saturation but are much less
practical in the clinical setting. The distributed param-
eter model was evaluated in this study, and showed no
significant difference in myocardial blood flow between
single and dual bolus analysis in volunteers [100]. In pa-
tients with coronary artery disease, distributed parameter
modeling was able to detect reduced myocardial blood
flow at stress in all 12 stenotic vessels compared to 9 for
Fermi modeling. Comparison of single bolus versus dual
bolus values suggests that distributed parameter modeling
is less dependent on arterial input function saturation
than Fermi modeling. Distributed parameter modeling
showed excellent accuracy in detecting reduced myocar-
dial blood flow in all stenotic vessels.
Optimization of dual-saturation single bolus acquisition
for quantitative cardiac perfusion and myocardial blood
flow maps
Through a series of in vitro and in vivo experiments, a
dual-saturation acquisition strategy was compared to the
standard dual-bolus strategy for quantification of myo-
cardial blood flow. Adequate flow estimation by the
dual-saturation strategy was achieved with myocardial
tissue saturation times around 100ms (always <30ms of
AIF), with the lowest echo time, and following a signal
model for contrast conversion that takes into account
the residual R2* effect and profile ordering. With these
settings, there was a good correlation and agreement be-
tween myocardial perfusion quantitation by dual-saturation
and dual-bolus techniques (R2 = 0.92). The dual-saturation
acquisition strategy produces accurate estimates of absolute
myocardial perfusion, and may be applied with minimal
interference in standard clinical procedures [101].
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Quantitative three-dimensional myocardial perfusion
cardiovascular magnetic resonance with accurate
two-dimensional arterial input function assessment
Quantification of myocardial perfusion from first-pass
CMR at high contrast agent (CA) dose requires separate
acquisition of blood pool and myocardial tissue enhance-
ment. In this study, a dual-sequence approach interleaving
2D imaging of the arterial input function with high-
resolution 3D imaging for myocardial perfusion assessment
was presented and validated for low (0.025 mmol/kg) and
high (0.1 mmol/kg) CA dose [102]. Most robust myocar-
dial blood flow estimation was achieved using the arterial
input function extracted from the 2D image at high CA
dose. Interleaving 2D imaging for arterial input function
assessment enables robust quantitative 3D myocardial per-
fusion imaging at high CA dose.
Myocardial perfusion is impaired in asymptomatic renal
and liver transplant recipients: a cardiovascular magnetic
resonance study
CMR was used to assess silent myocardial ischemia and
epicardial CAD in renal transplant recipients [103].
Twenty renal transplant (RT) patients with no known
CAD, fifteen liver transplant (LT) controls without prior
CKD or known CAD, and ten hypertensive (HT) con-
trols underwent CMR stress perfusion and coronary
angiography. Myocardial perfusion reserve was signifi-
cantly lower in the RT and LT groups compared to HT
controls, both in the subendocardium and subepicar-
dium. Seven (35%) RT and five (33%) LT had significant
epicardial CAD compared to none in HT controls. One
RT and one LT had LGE suggesting subendocardial in-
farction. RT recipients had impaired myocardial perfu-
sion independent of LVH or diabetes mellitus. The
impaired myocardial perfusion in RT was similar to LT
without prior renal disease, thus unlikely related to pre-
vious CKD. It is not fully explained by the presence of
significant epicardial CAD, and therefore most likely
represents microvascular CAD.
Individual component analysis of the multi-parametric
cardiovascular magnetic resonance protocol in the
CE-MARC trial
The CE-MARC study used a multi-parametric CMR
protocol assessing 4 components: i) left ventricular func-
tion; ii) myocardial perfusion; iii) viability [late gadolinium
enhancement (LGE)] and iv) coronary magnetic resonance
angiography (MRA). In this pre-specified sub-study, the
authors assessed the diagnostic accuracy of the individual
CMR components and their combinations [104]. The full
multi-parametric protocol had the highest sensitivity and
was the optimal approach to rule-out significant CAD.
The LGE component alone was the optimal rule-in
strategy. The inclusion of coronary MRA provided no
additional benefit when compared to the combination
of perfusion/function/LGE.
A review of 3D first-pass, whole-heart, myocardial perfusion
cardiovascular magnetic resonance
A comprehensive review was undertaken of the methods
available for 3D whole-heart first-pass perfusion (FPP)
and their application to date, with particular focus on
possible acceleration techniques [105]. Following a sum-
mary of the parameters typically desired of 3D FPP
methods, the review explains the mechanisms of key
acceleration techniques and their potential use in FPP for
attaining 3D acquisitions. Although many 3D FPP
methods are too early in development for the type of clini-
cal trials required to show any clear benefit over current
2D FPP methods, the review includes the small but
growing quantity of clinical research work already using
3D FPP, alongside the more technical work.
Impact of arrhythmia on diagnostic performance of
adenosine stress CMR in patients with suspected or
known coronary artery disease
This study evaluated the influence of arrhythmias on the
diagnostic performance of adenosine stress CMR [106].
Of the 159 patient enrolled, 72 had suspected CAD and
87 had known CAD. Diagnostic accuracy of adenosine
stress CMR for detection of significant CAD was 73%
for the entire population. Diagnostic accuracy was 75%
in patients with suspected CAD, and 74% in the group
with known CAD. For different types of arrhythmia,
diagnostic accuracy of CMR was 70% in the atrial fibril-
lation group, and 79% in patients with ventricular extra-
systoles. The present data demonstrate good diagnostic
performance of adenosine stress CMR for detection of
significant coronary stenosis in patients with arrhythmia
for work-up of suspected CAD or known CAD.
Quantification of myocardial blood flow with
cardiovascular magnetic resonance throughout the
cardiac cycle
The aim of this study was to determine if CMR quantita-
tive myocardial perfusion imaging accurately track
physiological variations in myocardial blood flow (MBF)
throughout the cardiac cycle in 30 healthy volunteers
[107]. The study showed that quantitative perfusion
CMR can be used to non-invasively assess cyclic varia-
tions in MBF throughout the cardiac cycle and that esti-
mates of stress MBF followed the expected physiological
trend, peaking at end-diastole and falling steadily through
to end-systole. This technique may be useful in future
pathophysiological studies of coronary blood flow and
microvascular function.
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Stress ventriculography
Mechanism of decreased sensitivity of dobutamine
associated left ventricular wall motion analyses for
appreciating inducible ischemia in older adults
Dobutamine associated left ventricular (LV) wall motion
analysis exhibit reduced sensitivity for detecting indu-
cible ischemia in individuals with increased LV wall
thickness. This study was performed to better under-
stand the mechanism of this reduced sensitivity in an
elderly population [108]. All participants with inducible
LV wall motion abnormalities (WMAs) had perfusion
defects (PDs). However, 60% of the participants who ex-
hibited PDs had no inducible WMAs on dobutamine.
Among these participants, myocardial oxygen demand
remained lower after accounting for LV afterload and
contractility, but not for either LV end-diastolic volume
(LV preload) or resting concentricity. In conclusion, despite
achieving target HR, a subset of elderly patients with risk
factors for CAD who undergo dobutamine stress experi-
ence perfusion abnormalities without a concomitant LV
WMAs. Mechanistically, this occurs in part due to a lower
myocardial oxygen demand that appears related to reduc-
tions in LV preload and increases in LV concentricity.
Downstream clinical consequences of stress
cardiovascular magnetic resonance based on appropriate
use criteria
The value of the most recent appropriate use criteria
(AUC) was tested in 300 consecutive patients referred
for CMR stress testing [109]. The results showed that
49.7% of stress CMRs were considered “appropriate”,
36.7% “maybe appropriate”, and 13.6% “rarely appropri-
ate”. Ischemia was significantly more likely in the “appro-
priate” and “maybe appropriate” groups than the “rarely
appropriate” group. No patients undergoing catheterization
in the “rarely appropriate” group went on to require revas-
cularization, in contrast to 53.3% of the “appropriate” and
36.4% of the “maybe appropriate” patients. The “rarely
appropriate” group never required revascularization, sug-
gesting suboptimal resource utilization. Studies classified
as “maybe appropriate” had similar rates of abnormal
findings and led to similar rates of downstream cathe-
terization and revascularization as those that were deemed
“appropriate”. This suggests that consideration could be
given to upgrading some of the common “maybe appro-
priate” indications to the appropriate category.
Assessment of cardiovascular physiology using
dobutamine stress cardiovascular magnetic resonance
reveals impaired contractile reserve in patients with
cirrhotic cardiomyopathy
Liver cirrhosis has been shown to affect cardiac per-
formance, which may only be revealed under stress con-
ditions. The authors performed a comprehensive CMR
analysis of systolic function and response to dobutamine
in 36 patients with cirrhosis and 8 controls [110]. Whilst
volumetric and deformation parameters were similar
between patients and controls at rest, patients with cir-
rhosis had a smaller increase in ejection fraction and
cardiac output during stress. This was paralleled by an
impaired improvement in circumferential, radial and
longitudinal strain as assessed by feature tracking. No
perfusion defects or late gadolinium enhancement were
identified in any patient. In conclusion, cirrhotic cardio-
myopathy is characterized by an impaired cardiac phar-
macological response that can be detected by CMR
stress testing.
Prognostic utility of cardiovascular magnetic resonance
upright maximal treadmill exercise testing
One hundred and fifteen (115) men and women with
known or suspected coronary arteriosclerosis underwent
an upright treadmill exercise CMR stress test in which
left ventricular wall motion abnormalities (LVWMA)
were identified before and immediately after exercise
[111]. All participants completed the testing protocol,
with 90% completing image acquisition within 60 s of
exercise cessation. The addition of CMR imaging identi-
fied those at risk for future events (p = 0.002), as opposed
to the electrocardiogram stress test alone (p = 0.63). The
results indicate that it is feasible to perform CMR wall
motion assessment immediately after upright maximal
treadmill exercise in patients with or suspected of coron-
ary artery disease. The presence of inducible LVWMA
during treadmill exercise stress CMR supplements ST seg-
ment monitoring and helps identify those at risk of the fu-
ture combined endpoints of myocardial infarction, cardiac
death, and unstable angina warranting hospitalization.
Myocardial infarction
CMR is widely used to study patients with ischaemic
heart disease and is particularly valuable to delineate
myocardial infarction using late gadolinium enhance-
ment, although more recently non-contrast techniques
to detect infarction have been described [112]. The use
of techniques to characterise components of myocardial
injury, [113] myocardial edema, myocardium at risk,
myocardial hemorrhage, [114] microvascular obstruction
[115] and hibernation, [116] has also grown.
Time elapsed after contrast injection is crucial to
determine infarct transmurality and myocardial functional
recovery after an acute myocardial infarction
The aim was to determine in acute and chronic MI
whether the imaging time after contrast injection influences
the LGE size that better predicts functional recovery [117].
Subjects were evaluated by cardiovascular magnetic
resonance (CMR) in the first week (n = 60) and 3
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months (n = 47) after a percutaneously revascularized
STEMI. In acute MI, LGE volume decreased with lon-
ger imaging times after contrast injection; however,
LGE volume remained constant over time in chronic
MI. Depending on the imaging time, a change in the
transmurality index was also observed in the acute
phase. Infarct transmurality at 25 min post-contrast in-
jection better predicted infarct size, functional recovery
and remodelling at follow-up.
Left ventricular global function index assessed by
cardiovascular magnetic resonance for the prediction
of cardiovascular events in ST-elevation myocardial
infarction
This study investigated the relationship between the
left ventricular global function index (LVGFI) and in-
farct characteristics as well as prognosis in a large
multicenter STEMI population [118]. LVGFI is defined
as (left ventricular stroke volume/left ventricular glo-
bal volume) x 100. The median LVGFI was 31.2%.
Patients with LVGFI < median had significantly larger
infarcts, less myocardial salvage, a larger extent of
microvascular obstruction, higher incidence of intra-
myocardial hemorrhage and more pronounced LV
dysfunction. MACE and mortality rates were signifi-
cantly higher in the LVGFI < median group. The
LVGFI had an incremental prognostic value in ad-
dition to LVEF for prediction of all-cause mortality,
offering prognostic information beyond traditional
cardiac risk factors.
T1 mapping and T2 mapping at 3T for quantifying the
area-at-risk in reperfused STEMI patients
Eighteen STEMI patients underwent CMR post primary
percutaneous coronary intervention using native T1
and T2 mapping at 3T [119]. Matching short-axis T1
and T2 maps covering the entire left ventricle (LV)
were assessed by two independent observers using
manual, Otsu and 2 SD thresholds. The acquisition
times were identical for the T1 and T2 maps. The Otsu
thresholding technique performed best in terms of in-
ter- and intra-observer variability for both T1 and T2
mapping CMR. There was no difference in either the
mean area at risk (AAR) or myocardial salvage index
between the T1 and T2 mapping techniques. On a per-
slice and per-patient analysis, there was an excellent
correlation between T1 mapping and T2 mapping in
the quantification of the AAR with no bias. T1 mapping
CMR at 3T performed as well as T2 mapping in quanti-
fying the AAR and assessing myocardial salvage in reper-
fused STEMI patients, thereby providing an alternative
CMR measure of the AAR.
Unrecognized myocardial infarctions assessed by
cardiovascular magnetic resonance are associated
with the severity of the stenosis in the supplying
coronary artery
This prospective multicenter study included 235 patients
with stable angina and no history of myocardial infarction
scheduled for coronary angiography [120]. The main goal
was to investigate the prevalence of unrecognized myocar-
dial infarction (UMI) by LGE CMR imaging prior to cor-
onary angiography. UMIs were found in 25% of patients.
There was a strong association between significant steno-
tic lesions (≥70% stenosis) in a coronary artery and the
presence of an UMI in the myocardial segments supplied
by the stenotic artery. Over half of the UMIs were located
in the inferior and inferolateral myocardial segments, des-
pite predominance for stenotic lesions in the left anterior
descending artery. In summary, UMI is common in pa-
tients with stable angina and the results indicate that the
majority of the UMIs are of ischemic origin due to severe
coronary atherosclerosis. In contrast to what is seen in
recognized myocardial infarctions, UMIs are predomin-
ately located in the inferior and inferolateral myocardial
segments.
Vascular disease
Other than its research role in vessel wall disease, CMR
is mainly used clinically for the carotid arteries, [121]
where it can be used to characterize plaque components,
[122, 123] plaque inflammation, [124] the carotid wall,
[125, 126] and disease progression [127]. MR angiog-
raphy is also making progress [128–130]. CMR is widely
used for assessment of the aorta in both congenital, gen-
etic, and acquired conditions and is particularly well suited
to assessment and longitudinal follow-up of aortic dimen-
sions, [131] outcomes, [132] and more complex aspects of
aortic function such as stiffness, [133] and stretch [134].
Site-specific association between distal aortic pulse
wave velocity and peripheral arterial stenosis severity:
a prospective cardiovascular magnetic resonance study
Atherosclerotic vascular disease is a diffuse pathological
process. Expression of the disease in one location may
not represent disease severity in other vascular territories
although strong correlation between disease expression
and severity within the same vascular segment may be ex-
pected. The authors prospectively compared the associ-
ation between distal aortic stiffness measured by CMR
pulse wave velocity (PWV) with the severity of peripheral
arterial occlusive disease [135]. Atherosclerotic markers
sampled in remote vascular territories such as PWV in the
proximal aorta and left common carotid artery wall thick-
ness was also compared. Distal aortic wall stiffness is more
directly related to peripheral arterial stenosis severity than
markers from more remote vascular territories such as
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proximal aortic wall stiffness or carotid arterial wall thick-
ness. Site-specific evaluation of vascular disease may be
required for full vascular risk estimation.
Evaluation of 3D multi-contrast joint intra- and extracranial
vessel wall cardiovascular magnetic resonance
Multi-contrast vessel wall CMR has demonstrated its cap-
ability for atherosclerotic plaque morphology measurement
and component characterization in different vasculatures.
However, limited coverage and partial volume effect with
conventional two-dimensional (2D) techniques might
cause lesion underestimation. Therefore the authors aimed
to evaluate the performance in a) blood suppression and b)
vessel wall delineation of three-dimensional (3D) multi-
contrast joint intra- and extracranial vessel wall imaging at
3T [136]. Three multi-contrast 3D black blood (BB) se-
quences with T1, T2 and heavy T1 weighting and a custom
designed 36-channel neurovascular coil covering the entire
intra- and extracranial vasculature were investigated. The
3D multi-contrast images acquired within 15 mins allowed
the vessel wall visualization with 0.8 mm isotropic spatial
resolution covering intra- and extracranial segments.
Quantitative wall and lumen SNR measurements for
each sequence showed effective blood suppression at
all selected locations (p < 0.0001). Although the wall-
lumen CNR varied across measured locations, each
sequence provided good or adequate image quality in
both intra- and extracranial segments. The authors
concluded that the proposed 3D multi-contrast vessel
wall technique provided isotropic resolution and time
efficient solution for joint intra- and extracranial vessel
wall CMR.
Inter-study reproducibility of interleaved spiral phase
velocity mapping of renal artery haemodynamics
Qualitative and quantitative assessment of renal blood
flow is valuable in the evaluation of renal and renovascular
diseases as well as in heart failure. In this study a high
temporal resolution interleaved spiral phase velocity map-
ping was developed at 3T to study temporal patterns of
flow and to measure renal flow resistive and pulsatility in-
dices which are measures of downstream resistance [137].
Inter-study and interobserver reproducibility of each vari-
able was also assessed. High temporal resolution breath-
hold spiral phase velocity mapping was shown to allow
reproducible assessment of renal resistive and pulsatility
indices as well as renal artery blood flow. Limitations of
the this study include absence of compassion of this tech-
nique with other methods currently employed, the limited
spatial resolution for vessel cross-sectional areas measure-
ments and the study cohort were relatively young volun-
teers only.
Effects of age and smoking on endothelial function
assessed by quantitative cardiovascular magnetic
resonance in the peripheral and central vasculature
Vascular reactivity was evaluated by CMR in young and
elderly non-smoker and smoker cohorts using cuff-
induced hyperemia via time-resolved blood flow velocity
and oxygenation (SvO2) in the femoral artery and vein,
respectively. SvO2 dynamics yielded washout time (time
to minimum SvO2), Arterial parameters included pulse
ratio, hyperemic index and duration of hyperemia [138].
In addition, pulse-wave velocity (PWV) was assessed in
the aortic arch. Age and smoking status were found to
be independent for all parameters and the results sug-
gest CMR biomarkers of endothelial function to be sen-
sitive to age and smoking independent of each other.
Ultrasound-based carotid intimal-medial thickness and
brachial flow-mediated dilation were measured for com-
parison. The authors acknowledged number of limitations
in the study design and the methods used including
operator-intensive data analysis which needs to be stream-
lined for future large-scale studies.
Gender specific patterns of age-related decline in aortic
stiffness: a cardiovascular magnetic resonance study
including normal ranges
Aortic stiffness was studied in a large cohort of healthy
volunteers using CMR aortic pulse wave velocity and
aortic distensibility measurements to assess gender spe-
cific patterns of age-related changes [139]. Aortic stiff-
ness increases with advancing age in both males and
females but a significant sex difference in the rate of
change exists, with females showing a steeper decline in
aortic elasticity. As aortic stiffness is strongly related to
cardiovascular events, these observations may explain
the increase in cardiovascular event rates that accom-
panies the menopausal age in women. Due to the cross-
sectional nature of the study, the actual effect of aging
within an individual on aortic stiffness would not be
possible to determine. Other limitations include brachial
pulse pressure assessment was used for determination of
aortic distensibility and not central blood pressure and
the study is exclusively in Caucasian limiting its applic-
ability to other populations.
Estimation of aortic pulse wave transit time in
cardiovascular magnetic resonance using complex
wavelet cross-spectrum analysis
CMR measured aortic pulse wave velocity is a well-
established method for assessing aortic stiffness. CMR
offers reliable segmental measurement of arterial length
but accurate transit time (TT) determination remains a
challenge. The authors developed a wavelet-based method,
which enables temporal localization of signal frequencies,
to estimate TT from ascending and descending aortic
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CMR flow curves and applied it to 71 healthy subjects
(29 females) [140]. The proposed method combines the
robustness of Fourier-based methods to low temporal
resolution with the possibility to restrict the analysis to
the reflectionless systolic upslope. The results showed
that CMR measurement of aortic arch flow TT using
systolic upslopes resulted in a better correlation with
age and applanation tonometry at carotid and femoral ar-
terial sites. Furthermore, methods based on harmonic de-
composition were less affected by low temporal resolution.
Arterial spin labeling perfusion cardiovascular magnetic
resonance of the calf in peripheral arterial disease:
cuff occlusion hyperemia vs exercise
Assessment of calf muscle perfusion requires a physio-
logical challenge. Exercise and cuff-occlusion hyperemia
are commonly used methods, but it has been unclear if
one is superior to the other. The authors hypothesized
that post-occlusion calf muscle perfusion (Cuff ) with
pulsed arterial spin labeling (PASL) CMR at 3T would
yield greater perfusion and improved reproducibility
compared to exercise hyperemia in studies of periph-
eral arterial disease (PAD) [141]. Subjects exercised
until exhaustion (15 NL-Ex, 15 PAD-Ex) or had a
thigh cuff inflated for 5 min (12 NL-Cuff, 11 PAD-
Cuff ). Controls had greater perfusion than PAD inde-
pendent of stressor (NL-Ex 74 ± 21 vs. PAD-Ex 43 ±
10, p = 0.01; NL-Cuffmean 109 ± 39 vs. PAD-Cuffmean
34 ± 17 ml/min-100 g, p < 0.001). However, there was
no difference between exercise and Cuffmean perfu-
sion within groups (p > 0.6). The authors concluded
that cuff hyperemia differentiated PAD patients from
controls, as did exercise stress. Cuffmean and exercise
calf perfusion values were similar. Cuff occlusion hyperemia
had superior reproducibility and thus might be the pre-
ferred stressor.
Vascular and plaque imaging with ultrasmall
superparamagnetic particles of iron oxide
Ultrasmall superparamagnetic iron oxide particles (USPIO)
are taken up by macrophages and can be identified in vivo
by CMR. T2 and T2*-weighted imaging provide a sensitive
method of assessing USPIO accumulation in tissues. In this
concise and well-written review, the authors address the
basic concepts, developments and applications of novel
USPIOS contrast agents for CMR studies of vascular in-
flammation and atherosclerotic plaques imaging [142].
Real-time aortic pulse wave velocity measurement during
exercise stress testing
The validity of CMR real-time aortic PWV measurements
during exercise was demonstrated in healthy subjects [143].
A velocity-sensitive real-time acquisition was adapted to
provide interleaved acquisition of two locations in the
descending aorta at 7.8 ms temporal resolution. An auto-
mated method was used to calculate the foot-to-foot transit
time of the velocity pulse wave. Comparable PWV mea-
surements were obtained from the standard 2D gated phase
contrast velocity encoding method in phantoms. Normal
volunteers showed an increase in PWV with age, and
an increase in PWV with exercise. The results suggest
this method would be feasible for evaluation of patients
with systemic aortic pathologies.
Non-invasive measurement using cardiovascular magnetic
resonance of changes in pulmonary artery stiffness
with exercise
The impact of exercise on pulmonary artery stiffness
was investigated in healthy subjects using CMR mea-
sured pulmonary artery pulse wave velocity and relative
area change [144]. Main pulmonary artery stiffness were
shown to increase in response to acute moderate exer-
cise in healthy subjects and that CMR exercise stress
offers potential non-invasive assessment of vascular
function in this setting. The study has a number of limi-
tations including both stiffness metrics are based on
measurement of the cross vascular sectional area and
therefore variations in the orientation and position of
the imaging plane could introduce error. The PWV
method is also assumes unidirectional wave propagation
along the vessel, which is only the case when reflective
waves are not present. In addition, short temporal reso-
lution is a crucial factor for accurate measurement
PWV considering the short path of the main pulmonary
artery.
Detection of elevated right ventricular extracellular
volume in pulmonary hypertension using Accelerated and
Navigator-Gated Look-Locker Imaging for Cardiac T1
Estimation (ANGIE) cardiovascular magnetic resonance
Evaluation of diffuse right ventricular fibrosis in the
setting of pulmonary hypertension (PH) is challenging
but clinically important. Current CMR T1 mapping
techniques have limited resolution, but accelerated and
navigator-gated Look-Locker imaging for cardiac T1
estimation (ANGIE) is a novel CMR sequence with
spatial resolution suitable for T1 mapping of the RV
[145]. The authors use this technique for assessment of
RV fibrosis and compared with normal volunteers and
patients with LV heart failure and reduced ejection
fraction (HFrEF) without co-existing PH, independent
RV dilatation and dysfunction. Pre- and post-contrast
ANGIE imaging provides high-resolution ECV deter-
mination for the RV. PH is independently associated
with increased RV-ECV even after adjustment for RV
dilatation and dysfunction, consistent with an independent
effect of PH on myocardial fibrosis.
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Left ventricular diastolic dysfunction in pulmonary
hypertension predicts functional capacity and clinical
worsening: a tissue phase mapping study
Pulmonary hypertension (PH) related changes in the
right ventricle can lead to abnormal left ventricular me-
chanics. The authors implemented novel CMR tissue phase
mapping (TPM) to assess radial, longitudinal and tangen-
tial LV myocardial velocities in patients with PH [146]. The
results show that TPM metrics of LV diastolic function are
significantly abnormal in PH. Abnormal LV E-wave veloci-
ties were found to be the only independent predictors of
functional capacity and clinical worsening in a model that
includes conventional metrics of biventricular function.
Congenital heart disease
CMR of congenital heart disease is well established,
although high quality acquisition and interpretation re-
quire training. CMR is used in fetuses, [147] children,
[148, 149] and adults, [150–152] often as a complement
to echocardiography, to avoid imaging with ionising ra-
diation, and reduce the need for invasive diagnostic car-
diac catheterisation. CMR has a proven role in coronary
anomalies, [153, 154] sudden cardiac death, [155] and
pulmonary arterial hypertension [156]. Four D flow im-
aging, which allows the visualisation of large scale vorticity
and the retrospective measurement of flow in vessels
within the volume covered, [157] continues to be of
interest.
Clinical validation of free breathing respiratory triggered
retrospectively cardiac gated cine balanced steady-state
free precession cardiovascular magnetic resonance in
sedated children
The authors prospectively studied two different cine
bSSFP sequences applied in 20 sedated children with
congenital heart disease mean age 8 years [158]. The
standard multi signal averaged was compared with a
prospective respiratory triggered bSSFP sequence. There
was improved image quality with respect to edge detec-
tion although there were no consequent differences in
the variability of LV and RV volumes between techniques.
The finding have clinical importance for CMR in free
breathing or sedated children and the improved edge defi-
nition was without a penalty in total clinical scan time.
Foetal blood flow measured using phase contrast
cardiovascular magnetic resonance - preliminary data
comparing 1.5T with 3.0T
CMR phase contrast blood flow quantification recon-
structed with metric optimised gating is described at 2
field strengths in a small cohort of 5 late gestation (35–38
weeks) fetuses [159]. CMR flow measures were obtained
in 36 of 40 target vessels. Increased signal to noise ratio
allowed better visualisation in smaller pulmonary vessels
at 3.0 T which improved inter-observer agreement.
Free breathing contrast-enhanced time-resolved magnetic
resonance angiography in pediatric and adult congenital
heart disease
The aim of this study was to compare a free-breathing
(FB) time resolved MR angiography (TRA) technique
with a conventional breath-hold MRA sequence in pe-
diatric (age > 8 years) and adult congenital heart disease
(n = 45) patients [160]. The FB-TRA sequence combines
time efficient spiral trajectories with sensitivity encoding
and partial Fourier to enable data acquisition of a 3D
volume every ~1.3 seconds without temporal data
sharing. FB-TRA proposed technique has sharper vessel
delineation and shorter imaging time (~1.3 s) but com-
pared with conventional MRA, the technique had inferior
signal-to-noise ratio, contrast-to-noise ratio, and relative
contrast. The vessel diameters and diagnostic accuracy
measured from the conventional and free-breathing
MRAs were also comparable. The main benefit of the pro-
posed technique is its imaging time that simplifies bolus
timing albeit with a long reconstruction time requirement
and allows free-breathing acquisition of MRA images in
patients unable to hold their breath.
Use of a 1.0 Tesla open scanner for evaluation of
pediatric and congenital heart disease: a retrospective
cohort study
The authors present their retrospective cross-sectional
institutional experience of open 1.0 T CMR compared to
1.5 T CMR for paediatric CMR or adults with congenital
heart disease [161]. The patients were mainly adoles-
cents and adults (median age 17 years). Half of patients
studied had congenital heart disease. Half of the experience
of open CMR was due to scheduling and 16% due to
elective choice for claustrophobia or body size. 1.0 T CMR
was able to answer most clinical questions and may have a
role for selected patients.
Characterization and quantification of dynamic eccentric
regurgitation of the left atrioventricular valve after
atrioventricular septal defect correction with 4D Flow
cardiovascular magnetic resonance and retrospective
valve tracking
Building on previous work applying 4D flow to LV in-
flow in this condition, 32 patients after repair of atrio-
ventricular septal defect (AVSD) were studied aiming to
characterise postoperative left atrioventricular valve re-
gurgitation (LAVV) present in 8 patients [162]. CMR 4D
flow measures were correlated with echocardiography
and CMR derived ventricular volumes and planimetry.
4D flow with retrospective valve tracking may be helpful
to accurately and directly quantify regurgitation from
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the potentially multiple, eccentric and non-circular shaped
LAVV regurgitation jets after repair of AVSD.
4D flow cardiovascular magnetic resonance consensus
statement
This informative consensus paper is the work of physi-
cists, physicians and biomedical engineers, active in the
development and implementation of 4D flow CMR and
describes the current advantages and disadvantages of
this approach [163]. 4D flow CMR enables comprehen-
sive access to all regions, planes and directions of car-
diovascular flow and can now be achieved with typical
spatial resolution of 1.5 × 1.5 × 1.5 – 3 × 3 × 3 mm3, typi-
cal temporal resolution of 30–40 ms, and acquisition
times in the order of 5 to 25 min. After placement of a
single acquisition volume, flow through any plane may
be calculated retrospectively and with good accuracy.
Research and development goals to be achieved are out-
lined in the statement. The clinical utility of 4D flow
CMR requires further evaluation in larger prospective
and multicenter trials. Meanwhile consensus example
clinical indications are given.
Atlas-based analysis of 4D flow CMR: Automated vessel
segmentation and flow quantification
This study aimed to develop and evaluate a fully auto-
matic method for segmentation and analysis of 4D flow
CMR data of the great thoracic vessels [164]. Improve-
ment and automation of post processing of 4D flow is
important towards moving 4D flow into clinical practice.
The proposed method was evaluated in 21 subjects
(11 volunteers and 10 heart failure patients with varying
degrees of valvar regurgitation) mean age 67 years studied
at 3T. Evaluation of the method was performed visually,
and by comparison of net flow volumes in the ascending
aorta obtained automatically (using the proposed method),
and semi-automatically. The proposed method allows
automatic 4D vessel segmentation, assessment of flow in
any number of image planes and 4D flow pattern visuali-
sation in a relatively short amount of time and without
user interaction.
Left ventricular fluid kinetic energy time curves in heart
failure from cardiovascular magnetic resonance 4D
flow data
Patients with heart failure (n = 29, NYHA class I-IV) and
controls (n = 12) underwent 4D flow CMR [165]. The
authors used a quantitative approach to global LV per-
formance as defined by the kinetic energy within the LV
volume across the cardiac cycle and separated volume
into regions defined by vortical or non-vortical flow
across a range of left ventricular function. Patients with
heart failure exhibit higher systolic average kinetic energy
compared to controls, suggesting altered intracardiac blood
flow. The different KE time curves in patients may provide
a new conceptual approach for heart failure classification.
Cardiovascular magnetic resonance catheterization
derived pulmonary vascular resistance and medium-term
outcomes in congenital heart disease
The authors report their extensive institutional experience
with pulmonary vascular resistance (PVR) measurement
using hybrid CMR and fluoroscopic guided cardiac cathe-
terisation in a cohort of patients with congenital heart
disease [166]. This method was previously validated by the
same group and shown to be superior to Fick’s method as
CMR flow measurement in independent of assumptions.
In addition to additional diagnostic value it also allows a
radiation-free or minimal radiation alternative for patients.
The study cohort is 149 patients (mainly children; median
age 3.6 years; range 6 days to 67 years) in whom 167 hy-
brid studies were performed. Mid-term clinical outcomes
(4.2 years) following clinical decisions that included con-
sideration of the results of PVR assessment are described.
Patients with biventricular physiology and shunt lesions
were studied to decide on whether or not the shunt com-
munication can be closed. Patients with univentricular
physiology were studied to decide on the suitability for the
Fontan palliation. Hybrid PVR assessment is safe and en-
ables reliable PVR assessment for risk stratification for
CHD patients. CMR/XMR catheterisation may have par-
ticular clinical value in planning and preparing Fontan
completion.
Non-invasive determination by cardiovascular magnetic
resonance of right ventricular-vascular coupling in children
and adolescents with pulmonary hypertension
Seventeen patients (aged 3 months to 23 years) with
available conventional right ventricular-vascular coupling
ratio (VVCR) data from invasive catheterisation within 14
days were studied with CMR with the aim to retrospect-
ively study the feasibility of non-invasive CMR measures
to estimate VVCR in paediatric pulmonary hypertension
(PH) patients [167]. The current interest in the clinical
utility of right ventricular-pulmonary arterial coupling
measurements was extended to a paediatric population
and correlation with vascular reactivity, a well-known sur-
rogate marker of disease in pulmonary hypertension was
also made. CMR derived VVCR correlated with the inva-
sive VVCR measure, the indexed pulmonary vascular re-
sistance and vascular reactivity. The small number of
patients included were heterogeneous and comprised of
idiopathic PAH, congenital heart disease, interstitial lung
disease and left heart disease, with both pediatric and
adult patients. The use of CMR derived VVCR may have
significant prognostic implication and will require further
study in larger numbers, restricted to children and with
less heterogeneous underlying PH causes.
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Single centre experience of the application of self
navigated 3D whole heart cardiovascular magnetic
resonance for the assessment of cardiac anatomy in
congenital heart disease
The authors describe their institutional experience of
using free-breathing self-navigated 3D-CMR in 105 con-
genital heart disease patients mean age 23 years at 1.5T
[168]. Younger age, higher heart rate, lower ejection
fraction and lack of contrast medium were independently
associated with reduced image quality. Future studies are
needed to compare the image quality of the self-navigated
3D SSFP to the standard respiratory navigator technique.
Electrophysiology
Distribution of abnormal potentials in chronic myocardial
infarction using a real time magnetic resonance guided
electrophysiology system
The authors conducted MR-guided electrophysiology
(EP) procedures in 6 pigs, 4 weeks after an induced
myocardial infarction by balloon occlusion of the left
anterior descending after the second diagonal branch
[169]. Infarct core, grey zone and normal myocardium
were imaged with a multi contrast late enhancement
CMR sequence. Abnormal local electrogram (EGM) po-
tentials at invasive electrophysiology were correlated
with CMR derived structural information relating to scar
and grey zone. Based on these animal data the authors
conclude that abnormal potentials and associated pro-
arrhythmogenicity are most prevalent in the CMR de-
fined grey zone. The correlation of LGE CMR grey zone
and abnormal potentials was highest when EP mapping
was in RV pacing rather than in sinus rhythm. These
data justify future investigation of the potential clinical
utility of VT ablation using CMR gray zone information.
Quantification of atrial dynamics using cardiovascular
magnetic resonance: inter-study reproducibility
Sixteen healthy volunteers underwent 3 CMRs on the
same day and left atrium (LA) and (right atrium) RA
reservoir, conduit and contractile booster pump func-
tions were quantified by volumetric indices as derived
from fractional volume changes and strain and strain
rate deformation measured from feature tracking CMR
[170]. For the LA the long axis 2- and 4-chamber views
were used and for the RA the 4 chamber view. There
was no morning to afternoon diurnal variation in atrial
function. Inter-study reproducibility was better for volu-
metric indexes with equal reproducibility of these mea-
sures in the LA and RA. Reproducibility for CMR
feature tracking derived strain was better than for strain
rate, and was better for the LA than for the RA. LA res-
ervoir function was the most reproducible measure of
LA function whether by volumetric, strain or strain rate.
Single breath-hold 3D measurement of left atrial volume
using compressed sensing cardiovascular magnetic
resonance and a non-model-based reconstruction
approach
The method proposed is a new approach to high spatial
and temporal resolution multi-slice cine imaging of the
left atrium (LA) in a single breath hold which is com-
bined with a non-model-based 3D reconstruction [171].
Compressed sensing with rate 11 undersampling was
employed to achieve a spatial resolution of 1.5x1.5 mm2
of a 6 mm slice at 30 ms temporal resolution. A total of
5 slices was acquired in a 20 second breath-hold. The se-
quence was validated using LA phantoms and tested on
3 patients relative to a navigated single mid-diastole
phase 3D acquisition. A high intra-and inter-observer
agreement was shown for maximal and minimal LA
volume measurement.
Prognostic value of pulmonary vein size in prediction of
atrial fibrillation recurrence after pulmonary vein
isolation: a cardiovascular magnetic resonance study
CMR assessment of pulmonary vein anatomy with first-
pass contrast enhanced magnetic resonance angiography
was correlated with rate of recurrence of atrial fibrilla-
tion (AF) after pulmonary vein isolation at catheter abla-
tion in a prospective study of 71 patients with either
paroxysmal, persistent or permanent AF [172]. Larger
pulmonary vein size (top 10th percentile in one or more
pulmonary veins), increased left atrial size and non-
paroxysmal AF were independently associated with in-
creased recurrence of AF after pulmonary vein isolation.
Patients with all 3 risk factors had a very high rate of
recurrent AF.
Left atrial structure and functional quantitation using
cardiovascular magnetic resonance and multimodality
tissue tracking: validation and reproducibility assessment
Twenty subjects with cardiovascular events and 10 healthy
subjects with total mean age 71 were assessed with multi-
modality tissue tracking (MTT) and CMR derived left
atrial (LA) volume and function [173]. The authors com-
pared the accuracy of LA biplane volume and function
measured by MTT and in the secondary analysis com-
pared the inter-study reproducibility for CMR derived LA
volume and function parameters. The authors conclude
that LA biplane volume and function is accurate and
reproducible with image analysis only half as time con-
suming. The intra and inter reader reproducibility for
MTT was good-excellent but the interstudy reproduci-
bility was fair-good.
Animal studies
The use of animals to study cardiac physiology and me-
tabolism continues to contribute a small but important
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section to the journal, to investigate basic principles and
novel ideas, recently for example in perfusion, [174, 175]
flow, [176] oxygenation, [177, 178] diffusion, [179] and
fibrosis [180].
Time course of cardiometabolic alterations in a high fat
high sucrose diet mice model and improvement after
GLP-1 analog treatment using multimodal cardiovascular
magnetic resonance
Abdesselam et al. used single voxel 1H-MR spectroscopy
to measure triglyceride content in heart and liver in a
high fat high sucrose diet mouse model [181]. The spec-
troscopic measurements were complemented with cine
and myocardial perfusion CMR. The multi-parametric
CMR protocols were applied longitudinally in these diet
induced obese mice to demonstrate that increase in
hepatic and cardiac steatosis preceded alteration of per-
fusion and cardiac function. The authors further showed
a beneficial effect of Exendin-4 on cardiac parameters
and both hepatic and cardiac steatosis, which may repre-
sent a potential therapeutic target.
Compressed sensing to accelerate magnetic resonance
spectroscopic imaging: evaluation and application to
23Na-imaging of mouse hearts
Maguire et al. evaluated the performance of Compressed
Sensing accelerated MRSI, and applied this technique to
obtain accelerated sodium maps of mouse hearts in vivo
[182]. More specifically, this study investigated the de-
pendence of resolution, signal-to-noise ratio (SNR) and
undersampling factor on spectral quality, and showed
that signal amplitudes could accurately be determined
with up to 5-fold under-sampled, CS-reconstructed MRSI.
Importantly, the results from this study are equally applic-
able to other nuclei and tissues and by no means restricted
to sodium MRSI of mouse hearts.
Two repetition time saturation transfer (TwiST) with
spill-over correction to measure creatine kinase reaction
rates in human hearts
31P-saturation transfer (ST) allows for measuring the
rate of ATP generation from phosphocreatine (PCr) via
creatine kinase (CK) in the myocardium, and various ap-
proaches have previously been reported to reduce the
scan time requirements for these intrinsically long ex-
periments. Schar et al validated here a two-repetition
time ST (TwiST) method, which omits the acquisition
with γ-ATP saturation and short repetition time, but in-
stead assumes an intrinsic relaxation time T1 for PCr
[183]. The pseudo-first-order rate constant kf obtained
with TwiST was found to be the same as the one mea-
sured with the triple-repetition time ST (TRiST)
method, but the acquisition was 9 min faster. Applied to
heart failure patients, TwiST agreed with previously
reported significant reductions in CK kf in this patient
group compared to healthy subjects, albeit at signifi-
cantly reduced scan times.
Left ventricular mechanical dysfunction in diet-induced
obese mice is exacerbated during inotropic stress: a cine
DENSE cardiovascular magnetic resonance study
Haggerty et al. evaluated LV mechanics under both resting
and stress conditions in a murine obesity model to investi-
gate whether or not LV mechanical dysfunction associated
with obesity is exacerbated with stress and manifested at
earlier stages of disease compared to baseline [184]. Cine
displacement encoding with stimulated echoes (DENSE)
with a temporal resolution of 7.4 ms was applied at rest
(baseline) and at pharmacologically induced stress longitu-
dinally over a period of 55 weeks. They found not only
that differences in left ventricular mechanics in obese
mice were exacerbated under stress conditions, but also
that stress CMR revealed differences earlier than investi-
gations at rest. The authors concluded that it may be im-
portant to evaluate cardiac function in the setting of
obesity under stress conditions to fully elucidate the pres-
ence of ventricular dysfunction.
Positive contrast high-resolution 3D-cine imaging of the
cardiovascular system in small animals using a UTE
sequence and iron nanoparticles at 4.7, 7 and 9.4T
Trotier et al. demonstrated in mice that 3D ultra-short
echo time (UTE) multi-frame MRI can generate positive
contrast independent of magnetic field strength or Ultra
Small Particles of Iron Oxide (USPIO) concentration
with high spatial and temporal resolution [185]. Specific-
ally, the cine-images, which provided high SNR and
CNR, did not suffer from flow or motion artifacts, and
allowed for visualization of coronary arteries and the
aortic valve. This approach may add to the portfolio of
available techniques to provide accurate cardiac function
assessment in small animal models of cardiovascular
disease.
Fast T2 gradient-spin-echo (T2-GraSE) mapping for
myocardial edema quantification: first in vivo validation
in a porcine model of ischemia/reperfusion
Fernández-Jiménez et al. reported on the implementation
and in vivo validation of a T2 gradient-spin-echo [GraSE])
for fast and accurate myocardial T2-mapping in hearts of
pigs [186]. Myocardial tissue was extracted for quantifica-
tion of myocardial water content at different time points
post closed chest ischemia-reperfusion surgery. Compared
to a standard T2-TSE method, T2-GraSE showed excel-
lent agreement with a mean T2 relaxation time difference
of only 0.1 ms. Furthermore, both techniques showed
good correlations with myocardial water content. Import-
antly, short acquisition and no requirement for specific
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software for data acquisition or post-processing allows for
this approach to be easily integrated into clinical routine.
Distal coronary embolization following acute myocardial
infarction increases early infarct size and late left
ventricular wall thinning in a porcine model
CMR was used to investigate the effects of no-reflow on
myocardial infarction and subsequent cardiac remodelling
changes following distal coronary embolization (DCE) of
biologically active, blood clot material in a porcine AMI
model [187]. The authors showed that DCE, which was
sufficient to cause angiographic no-reflow, significantly in-
creased early infarct size without affecting global cardiac
function. However, there were no significant effects on
late infarct size or global or regional cardiac function. The
clinical significance of the observed increases in infarct
transmurality and wall thinning in the DCE group at the
late time point remained uncertain and requires further
investigations.
CMR and pacemakers
The increasing number of patients with MR-conditional
devices in situ continues to be accompanied by greater
CMR experience and more routine scanning of such pa-
tients, [188, 189] although stress perfusion has lagged
somewhat behind due to feasibility and safety concerns,
notably with regard to competitive pacing. Despite much
research, accurately predicting who will respond to im-
plantation of cardiac resynchronisation therapy (CRT)
has remained problematic. CMR has developed a strong
evidence base for its inclusion in the selection of patients
for CRT implantation, previously to predict deleterious
scar, but increasingly to predict response [190, 191].
Prediction of response to cardiac resynchronization
therapy using left ventricular pacing lead position and
cardiovascular magnetic resonance derived wall motion
patterns: a prospective cohort study
In this prospective study, the authors evaluate CMR pre-
dictors of response to CRT in a cohort of 33 patients
with 18 (55%) responders defined by echocardiographic
criteria (a reduction in LV end-systolic volume of at least
15%) [192]. Factors evaluated included a type II mech-
anical contraction pattern, the combination of a type II
pattern and the LV lead position in the latest contracting
site (T2CL), a true LBBB ECG pattern, and scar. On
multivariate analysis, T2CL was the only independent
predictor of response. Although a type 2 contraction
pattern has been shown to be associated with CRT re-
sponse, this original assessment for a type 2 pattern
combined with lead position located in the latest acti-
vated site represents an approach with compelling incre-
mental value.
Feasibility and safety of adenosine cardiovascular
magnetic resonance in patients with MR conditional
pacemaker systems at 1.5 Tesla
The authors retrospectively analyzed their experience of
performing adenosine stress CMR in 24 consecutive pa-
tients with MR conditional pacemakers who underwent
CMR for the evaluation of known or suspected CAD
[193]. Much attention is paid to the programming strat-
egies used during CMR stress testing. No arrhythmia oc-
curred as a result of any of the programming choices
designed to avoid competitive pacing or bradycardia as
appropriate. Although the population size is relatively
small, these data support the feasibility and safety of ad-
enosine stress MR in patients with MR conditional
PPMs and provide some guidance as to programming
choices for stress CMR.
Varia
The varia section contains papers of interest that do not
easily fall into a larger well described category, and in-
cludes valve disease, [194] ventricular function, [195–198]
mass, [199] and shape, [200] pericardium, [201] position
papers, [202] safety papers, [203] summary papers, [204]
reviews, [205] and errata [206, 207].
2015 update on acute adverse reactions to gadolinium
based contrast agents in cardiovascular MR. Large
multi-national and multi-ethnical population experience
with 37788 patients from the EuroCMR registry
In the latest analysis of this large cohort of patients from
the EuroCMR Registry, the authors present further data
strongly supporting the safe use of Gadolinium based
contrast agents in CMR, reporting on the frequency and
severity of adverse reactions related to more than double
the number of contrast doses administered compared
with the 2011 publication and with only two new severe
reactions [208]. Accepting the potential for significant
under-reporting, only 45 acute reactions due to contrast
occurred from 37788 doses administered, a rate of 0.12%
and of these 43 of the 45 were classified as mild. The
authors appropriately continue to conclude, that sup-
ported by these data, Gadolinium based contrast as a safe
contrast medium for CMR should no longer be consid-
ered ‘off-label’.
Pulmonary artery to aorta ratio for the detection of
pulmonary hypertension: cardiovascular magnetic
resonance and invasive hemodynamics in heart failure
with preserved ejection fraction
In this interesting prospective study, the authors evalu-
ated the power of pulmonary artery (PA) diameter, and
its ratio with aortic (Ao) diameter, on top of right ven-
tricular size, function and septomarginal trabeculation
(SMT) derived by CMR, to predict elevated mean
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pulmonary pressure measured by right heart cathe-
terization (RHC) and also prognosis in a relatively large
cohort of patients (n = 111) with heart failure and pre-
served left ventricular ejection fraction (HFpEF) [209].
Patients were classified into one of two groups, either
with or without moderate/severe pulmonary hyperten-
sion (PH), based on whether mean pulmonary artery
pressure (mPAP) was 30 mmHg or more by RHC. 64%
of patients were in the moderate/severe PH group by
this classification. Significant differences between groups
with and without moderate/severe PH were observed with
respect to PA diameter (30.9 ± 5.1 mm versus 26 ± 5.1
mm, p < 0.001), PA:Ao ratio (0.93 ± 0.16 versus 0.78 ±
0.14, p < 0.001), and SMT diameter (4.6 ± 1.5 mm versus
3.8 ± 1.2 mm; p = 0.008). While PA diameter measure-
ments and PA:Ao ratio showed reasonable inter-observer
agreement, measurement of SMT diameter and area as
well as RV free wall thickness failed to show reproduci-
bility. The strongest correlation with mPAP was found
for PA:Ao ratio (r = 0.421, p < 0.001). By ROC analysis,
the best cut-off for the detection of moderate/severe
PH was found for a PA:Ao ratio of 0.83 (area under curve
0.76). Over a mean follow-up of 22.0 ± 14.9 months,
event-free survival was significantly worse in patients with
a PA:Ao ratio ≥0.83 (log rank, p = 0.004), although the
event rates were mainly driven by hospitalisation rate.
By multivariable Cox-regression analysis, PA:Ao ratio
was the only independent predictor of event-free sur-
vival (p = 0.003).
Increased pericardial fat accumulation is associated with
increased intramyocardial lipid content and duration of
highly active antiretroviral therapy exposure in patients
infected with human immunodeficiency virus: a 3T
cardiovascular magnetic resonance feasibility study
In this prospective case-control study, the authors com-
pare magnetic resonance measures of intramyocardial
and pericardial fat in 27 human immunodeficiency virus
(HIV) seropositive patients on highly active antiretroviral
therapy (HAART) and 22 HIV seronegative volunteers
matched for age, ethnicity, body mass index and other
baseline characteristics [210]. The authors report that
pericardial fat volume at the level of the left main coron-
ary artery (33.4 cm3 vs. 27.4 cm3, p = 0.03), but not at
the level of the right ventricular free wall or the thick-
ness over the right ventricular free wall, was greater in
HIV seropositive patients. Intramyocardial lipid content
(assessed by magnetic resonance spectroscopy) was also
higher in HIV seropositive patients and there was correl-
ation with pericardial fat volume (r = 0.58, p < 0.0001). In
multivariable analysis limited by cohort size, pericar-
dial fat volume at the level of the left main coronary
artery remained significantly associated with HIV sero-
positivity. Pericardial fat volume at the level of the left
main coronary artery was also correlated with time
since HIV diagnosis and duration of HAART. Further-
more, pericardial fat volume at the level of the left
main coronary artery was greater in those with lipo-
accumulation. As acknowledged by the authors, the
clinical significance of the observed differences re-
mains to be established.
Prognostic value of cardiovascular magnetic resonance
derived right ventricular function in patients with
interstitial lung disease
This prospective study evaluated the prognostic value of
RVEF by CMR in 76 patients with interstitial lung
disease (ILD). Pulmonary hypertension was defined by
right heart catheterization [211]. The median RVEF was
lower in ILD patients with PH (43.1%) compared to
those without PH (53.8%). During a mean follow-up of
386 days, 13 severe events occurred. Multivariate Cox re-
gression analysis showed that RVEF independently pre-
dicted future events after adjusting for age, gender and
right ventricular fractional area change by echocardiog-
raphy. These results suggest that CMR derived RVEF
could be useful for risk stratification and clinical manage-
ment of ILD patients.
Quantitative assessment of paravalvular regurgitation
following transcatheter aortic valve replacement
The authors compared CMR and transthoracic echocardi-
ography (TTE) analysis of pre-operative and post-operative
aortic regurgitation in patients with severe aortic stenosis
undergoing TAVI or surgical AVR [212]. Post-procedure
aortic regurgitant fraction by phase-contrast velocity was
higher in the TAVI group than in the surgical AVR group.
When compared to CMR based quantitative analysis, TTE
underestimated the degree of paravalvular aortic regurgita-
tion, and in 48% of the TAVI patients, the paravalvular
aortic regurgitation was at least one grade more severe on
CMR. Paravalvular aortic regurgitation post TAVI when
assessed by TTE may in fact be more significant and may
require further evaluation by CMR.
The diagnostic value of iron oxide nanoparticles for
imaging of myocardial inflammation - quo vadis?
This is an informative and well-presented review of the
basic features of superparamagnetic iron oxide-based
contrast agents and the use of these agents in preclinical
and preliminary clinical studies of myocardial inflamma-
tion in the setting of acute myocardial infarction and
myocarditis [213]. The authors highlight the transla-
tional potential of these agents and possible research ap-
plications with regard to imaging and therapy.
Pennell et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:86 Page 22 of 30
Normal values for cardiovascular magnetic resonance in
adults and children
A comprehensive summary of normal values of cardio-
vascular parameters derived from CMR studies. An in-
valuable reference document to keep available on the
desktop [214].
Quantification of LV function and mass by cardiovascular
magnetic resonance: multi-center variability and consensus
contours
The measurement of LV mass and function by CMR is
very reproducible within a centre, but less is known
about inter-centre variability. In this study, 7 expert
readers from 7 expert centres analyzed 15 core datasets
with excellent reproducibility [215]. The multicentre
consensus dataset may be used for benchmarking or
training.
Fractal frontiers in cardiovascular magnetic resonance:
towards clinical implementation
Many of the structures and parameters that are detected,
measured and reported in CMR have at least some
properties that are fractal, meaning complex and self-
similar at different scales. To date however, there has
been little use of fractal geometry in CMR. This review
explains the fundamental principles of fractal geometry,
places the fractal dimension into a meaningful context
within the realms of Euclidean and topological space,
and defines its role in digital image processing [216]. It
summarises the basic mathematics, highlights strengths
and potential limitations of its application to biomedi-
cal imaging, shows key current examples and suggests a
simple route for its successful clinical implementation
by the CMR community. By simplifying some of the
more abstract concepts of deterministic fractals, this re-
view invites CMR practitioners to experiment with fractal
analysis as a means of developing the next generation of
intelligent quantitative cardiac imaging tools.
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